Shattuck Labs Inc (STTK)
1.43
+0.21
(+17.21%)
USD |
NASDAQ |
Nov 14, 13:13
Shattuck Labs Revenue (Quarterly): 1.609M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.609M |
| March 31, 2024 | 1.115M |
| December 31, 2023 | 0.714M |
| September 30, 2023 | 0.686M |
| June 30, 2023 | 0.20M |
| March 31, 2023 | 0.057M |
| December 31, 2022 | 0.39M |
| September 30, 2022 | 0.212M |
| June 30, 2022 | 0.05M |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | 30.08M |
| September 30, 2021 | 1.90M |
| June 30, 2021 | -4.231M |
| March 31, 2021 | 2.27M |
| December 31, 2020 | 1.342M |
| September 30, 2020 | 2.435M |
| June 30, 2020 | 3.181M |
| March 31, 2020 | 2.976M |
| December 31, 2019 | 2.821M |
| September 30, 2019 | 1.784M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-4.231M
Minimum
Jun 2021
30.08M
Maximum
Dec 2021
2.656M
Average
1.228M
Median
Revenue (Quarterly) Benchmarks
| CVS Health Corp | 95.43B |
| Johnson & Johnson | 22.47B |
| Bristol-Myers Squibb Co | 11.89B |
| IGM Biosciences Inc | 1.254M |
| Biohaven Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.55M |
| Total Expenses (Quarterly) | 24.57M |
| EPS Diluted (Quarterly) | -0.42 |
| Enterprise Value | -47.12M |
| Profit Margin (Quarterly) | -1.34K% |
| Earnings Yield | -129.4% |
| Normalized Earnings Yield | -129.37 |